David Duracher

David Duracher has over 25 years of work experience in various pharmaceutical and research roles. David is currently serving as the VP CMC at Amolyt Pharma since June 2020. Prior to this, David held the position of Director of Pharmaceutical Development at ADOCIA from January 2013 to June 2020. David also served as the Head of Physico-Chemistry Dpt at ADOCIA from June 2006 to December 2012. Furthermore, David worked at Flamel Technologies as a Drug Product formulation development specialist from March 2003 to May 2006. David was also involved in DNA chips development as an R&D scientist at APIBIO from May 2001 to February 2003. In addition, David has experience as a Postdoctoral Research Fellow at KCPC - Key Center For Polymer Colloids - Sydney University from December 1999 to March 2001 and as a Research Scientist at CNRS-BioMerieux from September 1995 to November 1999.

David Duracher received their Doctor of Philosophy (PhD) degree from Université Claude Bernard Lyon 1 between 1996 and 1999. No specific field of study is mentioned.